(Q40179554)

18 September 2017

1 reference

title

Carcinogenicity of antineoplastic agents in man (English)

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

author name string

K. Rieche

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6375862

11 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6375862

11 October 2023

publication date

1 March 1984

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0305737284900161?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

https://api.elsevier.com/content/article/PII:0305737284900161?httpAccept=text/plain

11 October 2023

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

published in

Cancer Treatment Reviews

1 reference

18 September 2017

volume

11

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

39-67

1 reference

Carcinoma of the Urinary Bladder in Patients Receiving Cyclophosphamide

18 September 2017

cites work

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1056/NEJM197508072930604

Combination therapy for multiple myeloma

1

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Identifying Environmental Chemicals Causing Mutations and Cancer

11 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myeloid leukaemia after treatment with cytostatic agents

11 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second Lymphoid Malignant Neoplasms Occurring in Patients Treated for Hodgkin's Disease

11 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy

11 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Risk of new cancers in patients with Hodgkin's disease

11 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second malignancy in patients treated by Hodgkin's disease

11 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Carcinoma of the breast. Occurence after treatment with melphalan for multiple myeloma

11 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

11 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Systemic chemotherapy for psoriasis: a national survey

11 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

11 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Malignant tumors in renal transplant patients the scandia transplant material

11 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease

11 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Secondary neoplasms in malignant lymphomas after intensive therapy

11 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Increasing frequency of acute myeloid leukemia complicating Hodgkin's disease: a review

11 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer

11 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Multiple primary cancer risk after therapy for Hodgkin's disease

11 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

11 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second malignancies complicating Hodgkin's disease in remission

11 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Association of cancer of the breast and acute myelocytic leukemia

11 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second tumors complicating cancer chemotherapy

11 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute Leukemia Following Prolonged Cytotoxic Agent Therapy

11 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

11 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myeloid leukaemia in the course of Hodgkin's disease (author's transl)

11 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second neoplasm--a complication of cancer chemotherapy

11 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Immunosuppressive Drugs and Acute Leukemia

11 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

Leukaemia on myeloma

44

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Decreased risk of radiation-associated second malignant neoplasms in actinomycin-d-treated patients

11 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia complicating metastatic breast cancer

11 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Longtime complications in patients with malignant lymphomas following chemo- and (or) radiotherapy. Virus infections--leukemias--sterility

11 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture

11 October 2023

51

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Reticulum Cell Sarcoma after Renal Homotransplantation and Azathioprine and Prednisone Therapy

11 October 2023

52

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myeloid leukemia following non-Hodgkin's lymphoma: danger of prolonged use of chlorambucil as maintenance therapy

11 October 2023

53

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Bladder cancer following administration of cyclophosphamide

11 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Extraosseous lesions in plasma cell myeloma. A report of six cases

11 October 2023

55

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia after chemotherapy (melphalan)

11 October 2023

57

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Emergence of acute non-lymphocytic leukemia in breast cancer patients

11 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

The Incidence Of Bladder Cancer after Cyclophosphamide Therapy

11 October 2023

59

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

Chemical carcinogenesis

60

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease

11 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Therapy-related leukemia. A panmyelosis

11 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Uroepithelial Carcinoma in Association With Cyclophosphamide Ingestion

11 October 2023

65

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Clinical use of immunosuppressive drugs: part I

11 October 2023

67

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute erythroleukemia following chemotherapy for Hodgkin's disease

11 October 2023

69

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute Leukemia in Multiple Myeloma

11 October 2023

70

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myelocytic leukemia following prolonged streptozotocin therapy

11 October 2023

71

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

11 October 2023

73

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myeloblastic leukemia after cure of ovarian cancer

11 October 2023

74

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases

11 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myeloid leukemia following treatment of Hodgkin's disease: a review

11 October 2023

76

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease

11 October 2023

78

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia following anticancer treatment

11 October 2023

79

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Leukemia in Patients Treated for Hodgkin's Disease

11 October 2023

81

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Malignancy During Methotrexate and Steroid Therapy for Psoriasis

11 October 2023

84

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Immunosuppressive Anticancer Drugs in Man: Their Oncogenic Potential

11 October 2023

85

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

The carcinogenicity of anticancer drugs: a hazard in man

11 October 2023

86

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

The estrogen-cancer hypothesis

11 October 2023

87

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

Epidemic acute leukemia

90

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Risk of cancer in renal-transplant recipients.

11 October 2023

91

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

Drug-induced cancer

93

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Tumor inductions by cytostatics in man

11 October 2023

94

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Pancreatic carcinoma as a sequel to therapy of lymphoma

11 October 2023

97

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Ovarian carcinoma terminating in acute nonlymphocytic leukemia following alkylating agent therapy

11 October 2023

98

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Induced acute non-lymphocytic leukemia following long-term chemotherapy: a study of 20 cases

11 October 2023

99

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Alkylating agents as leukemogens in multiple myeloma

11 October 2023

100

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second cancers after prolonged adjuvant thiotepa for operable carcinoma of the breast

11 October 2023

101

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute Leukemia Following Cytotoxic Chemotherapy

11 October 2023

102

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute Erythroleukemia Complicating Prolonged Chemotherapy for Ovarian Carcinoma

11 October 2023

104

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Endometrial carcinoma following estrogen therapy for breast cancer. Report of three cases

11 October 2023

105

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

11 October 2023

106

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Sideroblastic anemia as a preleukemic event in patients treated for Hodgkin's disease

11 October 2023

107

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease

11 October 2023

108

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Association of monosomy 7 with myelodysplasia following chemotherapy for Hodgkin's disease: serial observations

11 October 2023

110

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Breast Cancer, Chemotherapy, and Second Malignant Neoplasms

11 October 2023

113

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Multiple myeloma and acute myelomonocytic leukemia

11 October 2023

114

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Multiple myeloma and acute leukemia associated with alkylating agents

11 October 2023

115

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second malignancies associated with chemotherapeutic agents

11 October 2023

116

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer

11 October 2023

118

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis

11 October 2023

119

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Survivors of Cancer in Childhood

11 October 2023

120

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second malignant tumors after cancer in childhood

11 October 2023

121

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Lung Cancer in Chronic Leukemia and Lymphoma

11 October 2023

122

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease

11 October 2023

124

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Recommendations for the analysis of the effect of treatment on the development of second malignancies

11 October 2023

126

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Hazard of immunosuppressive therapy.

11 October 2023

127

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia following intensive therapy for small-cell carcinoma of the lung

11 October 2023

129

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Lung carcinoma after radiotherapy and chemotherapy for Hodgkin's disease

11 October 2023

131

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute Leukemia following Combination Chemotherapy for Cancer of the Lung

11 October 2023

132

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Adenocarcinoma of the lung during azathioprine therapy

11 October 2023

133

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant disease

11 October 2023

134

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Oncogenicity of immunosuppressive drugs

11 October 2023

135

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Oncogenesis and Other Late Effects of Cancer Treatment in Children

11 October 2023

137

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Enhancement of mammary tumor formation in mice by a cytostatic drug, melphalan

11 October 2023

138

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Incidence of second malignant neoplasms in children: results of an international study

11 October 2023

140

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy

11 October 2023

142

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 42-1978

11 October 2023

144

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia following chlorambucil therapy of advanced ovarian and fallopian tube carcinoma

11 October 2023

146

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

BREAST CANCER AND CYTOLOGIC DYSPLASIA IN MANY ORGANS AFTER BUSULFAN (MYLERAN)

11 October 2023

149

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second malignant neoplasms in patients treated for hodgkin's disease with radiotherapy or radiotherapy and chemotherapy

11 October 2023

150

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Secondary malignant neoplasms in patients with Hodgkin's disease

11 October 2023

151

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Myelomonocytic leukemia in Hodgkin's disease

11 October 2023

152

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Cytogenetic studies of bone marrow in breast cancer patients after adjuvant chemotherapy

11 October 2023

154

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy

11 October 2023

155

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma

11 October 2023

156

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)

11 October 2023

158

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Chemical immunosuppression and human cancer

11 October 2023

159

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second malignant neoplasms associated with immunosuppressive medications

11 October 2023

160

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Malignancies associated with immunosuppressive or cytotoxic therapy

11 October 2023

161

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia following cytotoxic chemotherapy

11 October 2023

162

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Erythroleukaemia in a Melphalan-Treated Patient with Primary Macroglobulinaemia

11 October 2023

163

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Cyclophosphamide and bladder carcinoma (case report) (author's transl)

11 October 2023

164

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Bladder Complications in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus or Rheumatoid Arthritis

11 October 2023

166

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia as a complication of long-term treatment of advanced breast cancer

11 October 2023

167

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myelogenous leukemia subsequent to therapy for a different neoplasm: Clinical features and response to therapy

11 October 2023

168

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Therapy of secondary acute nonlymphocytic leukemia with cytarabine

11 October 2023

169

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

Leukemia on myeloma

172

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Hodgkin's disease associated with other malignant tumors and certain non-neoplastic diseases

11 October 2023

174

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

AMINOPTERIN FOR PSORIASIS. A DECADE'S OBSERVATION.

11 October 2023

175

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

11 October 2023

177

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Lymphosarcoma: the effects of therapy and survival in 1,269 patients in a review of 30 years' experience

11 October 2023

181

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Other Tumors Complicating Hodgkin's Disease

11 October 2023

182

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature

11 October 2023

184

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature

11 October 2023

185

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia as a delayed consequence of cancer chemotherapy

11 October 2023

186

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Breast cancer and acute leukemia: Report of 24 cases and review of the literature

11 October 2023

187

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia as a complication of cytotoxic chemotherapy

11 October 2023

188

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

[Fibrosarcoma of the bladder after seven-year chemotherapy of Hodgkin's disease in childhood]

11 October 2023

191

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic Tumors

11 October 2023

192

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia in Hodgkin's disease.

11 October 2023

194

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Carcinoma of the Bladder With Azathioprine Therapy

11 October 2023

197

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Immunosuppressive and Cytotoxic Chemotherapy: Long-Term Complications

11 October 2023

198

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Experimental Investigations with Anti-Cancer Drugs for Carcinogenicity with Special Reference to Immunedepression

11 October 2023

199

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Toxicology in cancer research. I. Cancerogenic substances

11 October 2023

200

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Iatrogenic carcinogenesis

11 October 2023

202

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Plasmocytoma, alkylating agents, and acute myeloid leukemia (author's transl)

11 October 2023

203

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia in rheumatoid arthritis treated with cytotoxic agents

11 October 2023

206

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Methyl CCNU therapy linked leukemia

11 October 2023

207

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases.

11 October 2023

211

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Cytotoxic drug-induced lung disease

11 October 2023

212

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents

11 October 2023

213

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute erythroleukaemia in a patient treated with melphalan for the cold agglutinin syndrome

11 October 2023

214

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Chronic lymphocytic leukemia and subsequent cancer in the same patient

11 October 2023

215

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Solid Tumors in Multiple Myeloma

11 October 2023

216

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Cytotoxic drugs in treatment of nonmalignant diseases

11 October 2023

217

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy

11 October 2023

218

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Rapid onset of acute myeloid leukaemia following radiotherapy and chemotherapy for metastatic seminoma of the testis

11 October 2023

219

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukaemia after busulphan

11 October 2023

220

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Cancer and Teratogenesis: Infrequent Occurrence after Medical Use of Immunosuppressive Drugs*

11 October 2023

221

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myeloid leukaemia after treatment with cytostatic agents

11 October 2023

222

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Development of reticulum cell sarcoma during cyclophosphamide therapy

11 October 2023

223

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

CHLORNAPHAZINE AS A BLADDER CARCINOGEN

11 October 2023

226

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Preleukaemic abnormal myelopoiesis induced by chlorambucil: a case study

11 October 2023

230

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Second malignancies in Hodgkin's disease: a complication of certain forms of treatment

11 October 2023

232

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Unusual cases of myelomatosis.

11 October 2023

235

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute leukemia complicating treatment of glioblastoma multiforme

11 October 2023

236

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Hodgkin's disease terminating as acute leukaemia: case report and review of the literature

11 October 2023

239

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone

11 October 2023

240

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Chronic myeloid leukemia in myasthenia gravis after long-term treatment with 6-mercaptopurine

11 October 2023

241

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Incidence of multiple cancer

11 October 2023

243

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunological phenotype.

11 October 2023

244

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

The Carcinogenic Properties of Some of the Principal Drugs Used in Clinical Cancer Chemotherapy

11 October 2023

247

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents

11 October 2023

248

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Carcinogenesis due to mustard gas exposure in man, important sign for therapy with alkylating agents

11 October 2023

249

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Acute myeloid leukemia appearing in two patients after prolonged continuous chlorambucil treatment for Wegener's granulomatosis

11 October 2023

250

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Cyclophosphamide-Associated Leukemia in Wegener's Granulomatosis

11 October 2023

251

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Hodgkin's Disease Terminating in Acute Leukaemia: Report of Seven Cases

11 October 2023

254

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

Cyclophosphamide and the bladder

11 October 2023

255

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

The 13th report of the human renal transplant registry

11 October 2023

258

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90016-1

11 October 2023

Identifiers

1 reference

18 September 2017

1 reference